IDEAYA Biosciences, Inc. IDYA Proceeds From Issuance Of Common Stock At The Market Offering Program Net Of Issuance Cost
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept idya:ProceedsFromIssuanceOfCommonStockAtTheMarketOfferingProgramNetOfIssuanceCost.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s proceeds from issuance of common stock at the market offering program net of issuance cost.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s proceeds from issuance of common stock at the market offering program net of issuance cost?
- IDEAYA Biosciences, Inc. (IDYA) reported proceeds from issuance of common stock at the market offering program net of issuance cost of -$9K in Q1 2026.